Abstract
Natural killer T (NKT) cells have been shown to bridge innate and adaptive immunity. However, the rare population and hard-to-transfect of primary NKT cells slow down our understanding of cellular and molecular mechanisms of NKT development and function. To overcome these drawbacks, NKT hybridomas, especially DN32.D3 cells, are applied to study NKT cells in vitro and becoming a valuable tool. Here, we describe the method in the genetic manipulation of DN32.D3 cells by retrovirus, including the generation and concentration of retrovirus, retroviral transduction of DN32.D3 cells, and evaluation of transduction efficiency.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kronenberg M (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23:877–900. https://doi.org/10.1146/annurev.immunol.23.021704.115742
Nishioka Y, Masuda S, Tomaru U et al (2018) CD1d-restricted type II NKT cells reactive with endogenous hydrophobic peptides. Front Immunol 9:548. https://doi.org/10.3389/fimmu.2018.00548
Crosby CM, Kronenberg M (2018) Tissue-specific functions of invariant natural killer T cells. Nat Rev Immunol 18(9):559–574. https://doi.org/10.1038/s41577-018-0034-2
Bassiri H, Das R, Nichols KE (2013) Invariant NKT cells: killers and conspirators against cancer. Onco Targets Ther 2(12):e27440. https://doi.org/10.4161/onci.27440
Kakimi K, Guidotti LG, Koezuka Y et al (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192(7):921–930. https://doi.org/10.1084/jem.192.7.921
Geissmann F, Cameron TO, Sidobre S et al (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3(4):e113. https://doi.org/10.1371/journal.pbio.0030113
Kawano T, Cui J, Koezuka Y et al (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278(5343):1626–1629. https://doi.org/10.1126/science.278.5343.1626
Shimamura M, Ohteki T, Beutner U et al (1997) Lack of directed V alpha 14-J alpha 281 rearrangements in NK1+ T cells. Eur J Immunol 27(6):1576–1579. https://doi.org/10.1002/eji.1830270638
Kronenberg M (2014) When less is more: T lymphocyte populations with restricted antigen receptor diversity. J Immunol 193(3):975–976. https://doi.org/10.4049/jimmunol.1401491
Das R, Sant'Angelo DB, Nichols KE (2010) Transcriptional control of invariant NKT cell development. Immunol Rev 238(1):195–215. https://doi.org/10.1111/j.1600-065X.2010.00962.x
Lynch L, Nowak M, Varghese B et al (2012) Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37(3):574–587. https://doi.org/10.1016/j.immuni.2012.06.016
Santodomingo-Garzon T, Swain MG (2011) Role of NKT cells in autoimmune liver disease. Autoimmun Rev 10(12):793–800. https://doi.org/10.1016/j.autrev.2011.06.003
Lynch L, O'Shea D, Winter DC et al (2009) Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol 39(7):1893–1901. https://doi.org/10.1002/eji.200939349
Sebode M, Wigger J, Filpe P et al (2019) Inflammatory phenotype of intrahepatic Sulfatide-reactive type II NKT cells in humans with autoimmune hepatitis. Front Immunol 10:1065. https://doi.org/10.3389/fimmu.2019.01065
Singh AK, Tripathi P, Cardell SL (2018) Type II NKT cells: an elusive population with immunoregulatory properties. Front Immunol 9:1969. https://doi.org/10.3389/fimmu.2018.01969
Lantz O, Bendelac A (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180(3):1097–1106. https://doi.org/10.1084/jem.180.3.1097
Bendelac A, Lantz O, Quimby ME et al (1995) CD1 recognition by mouse NK1+ T lymphocytes. Science 268(5212):863–865. https://doi.org/10.1126/science.7538697
Brutkiewicz RR, Bennink JR, Yewdell JW et al (1995) TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. J Exp Med 182(6):1913–1919. https://doi.org/10.1084/jem.182.6.1913
Kain L, Webb B, Anderson BL et al (2014) The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity 41(4):543–554. https://doi.org/10.1016/j.immuni.2014.08.017
Zhou D, Cantu C 3rd, Sagiv Y et al (2004) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303(5657):523–527. https://doi.org/10.1126/science.1092009
Freigang S, Zadorozhny V, McKinney MK et al (2010) Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice. J Clin Invest 120(6):1873–1884. https://doi.org/10.1172/JCI40451
Albu DI, VanValkenburgh J, Morin N et al (2011) Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes. Proc Natl Acad Sci U S A 108(15):6211–6216. https://doi.org/10.1073/pnas.1014304108
Jordan-Williams KL, Poston S, Taparowsky EJ (2013) BATF regulates the development and function of IL-17 producing iNKT cells. BMC Immunol 14:16. https://doi.org/10.1186/1471-2172-14-16
Yang SH, Kim SJ, Kim N et al (2008) NKT cells inhibit the development of experimental crescentic glomerulonephritis. J Am Soc Nephrol 19(9):1663–1671. https://doi.org/10.1681/ASN.2007101117
Wang Y, Yun C, Gao B et al (2017) The lysine acetyltransferase GCN5 is required for iNKT cell development through EGR2 acetylation. Cell Rep 20(3):600–612. https://doi.org/10.1016/j.celrep.2017.06.065
van Eijkeren RJ, Morris I, Borgman A et al (2020) Cytokine output of adipocyte-iNKT cell interplay is skewed by a lipid-rich microenvironment. Front Endocrinol (Lausanne) 11:479. https://doi.org/10.3389/fendo.2020.00479
Huh JY, Kim JI, Park YJ et al (2013) A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol Cell Biol 33(2):328–339. https://doi.org/10.1128/MCB.00552-12
Wang K, Zhang X, Wang Y et al (2019) PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision. Cell Mol Immunol 16(9):746–756. https://doi.org/10.1038/s41423-018-0059-2
Kim HS, Kim HS, Lee CW et al (2010) T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production. J Immunol 184(8):4095–4106. https://doi.org/10.4049/jimmunol.0901991
Yu B, Zhang K, Milner JJ et al (2017) Epigenetic landscapes reveal transcription factors that regulate CD8(+) T cell differentiation. Nat Immunol 18(5):573–582. https://doi.org/10.1038/ni.3706
Yang M, Li D, Chang Z et al (2015) PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness. J Exp Med 212(2):253–265. https://doi.org/10.1084/jem.20141703
Shang Y, Coppo M, He T et al (2016) The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation. Nat Immunol 17(8):930–937. https://doi.org/10.1038/ni.3486
Naviaux RK, Costanzi E, Haas M et al (1996) The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 70(8):5701–5705. https://doi.org/10.1128/JVI.70.8.5701-5705.1996
Ciuculescu MF, Brendel C, Harris CE et al (2014) Retroviral transduction of murine and human hematopoietic progenitors and stem cells. Methods Mol Biol 1185:287–309. https://doi.org/10.1007/978-1-4939-1133-2_20
Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7(12):1063–1066. https://doi.org/10.1038/sj.gt.3301206
Lounkova A, Kosla J, Prikryl D et al (2017) Retroviral host range extension is coupled with Env-activating mutations resulting in receptor-independent entry. Proc Natl Acad Sci U S A 114(26):E5148–E5E57. https://doi.org/10.1073/pnas.1704750114
Acknowledgments
The authors thank Dr. Li Bai at the University of Science and Technology of China for the DN32.D3 hybridomas and Dr. Zhongjun Dong at Tsinghua University for the pCL-Eco and pMSCV-ubc-EGFP vectors. This work was supported by grants from the National Key Research and Development Program of China (2017YFA0104500), the National Natural Science Foundation of China (32070897, 31671244, 31872734), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001), Beijing Natural Science Foundation (7202079), and the Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences, 2019PT320006.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Wang, K., Jin, R., Ge, Q. (2021). Retroviral Transduction of NKT Hybridoma Cells. In: Liu, C. (eds) Invariant Natural Killer T-Cells. Methods in Molecular Biology, vol 2388. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1775-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1775-5_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1774-8
Online ISBN: 978-1-0716-1775-5
eBook Packages: Springer Protocols